Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic Launches Full-Body MRI-Compatible Defibrillator In Europe

This article was originally published in The Gray Sheet

Executive Summary

Medtronic announced the European launch its Evera MRI SureScan ICD system, the only implantable defibrillator approved to be compatible with full-body magnetic resonance imaging.

You may also be interested in...



Boston Makes Big European Push In MRI Compatibility

Boston Scientific says it now has the largest MRI-compatible portfolio in Europe with the recent CE marks for ImageReady labeling for a range of implantable defibrillators and cardiac resynchronization therapy devices.

Medtronic Pacing Lead Gets FDA Nod For Use With MRI

The pacing lead which has been in wide use since its introduction more than a decade ago joins Medtronic’s growing line of products approved for use with MRIs.

Medtronic Claims Clinical, Cost Advantages For Just-Launched Viva CRT-D

Viva is the first of Medtronic’s U.S. CRT-Ds to incorporate the proprietary AdaptivCRT algorithm designed to more readily adapt to a patient’s condition and optimize therapy. The firm also launched its Evera ICD last week.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel